VTVT
VTVT clinical trials: vTv Therapeutics Inc.
Every trial on ClinicalTrials.gov where vTv Therapeutics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 15
- Trials linked
- 14
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
VTVT on the catalyst calendar · VTVT registry changes
- Primary completion Jun 2027Sponsor estimatePhase 2NCT07616206Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) SystemsvTv Therapeutics · Type 1 Diabetes (T1D)RecruitingVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimatePhase 3NCT06334133Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesvTv Therapeutics · Diabetes Mellitus, Type 1Active, not recruitingVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 20, 2019ActualPhase 1/Phase 2NCT03335371Evaluation of TTP399 in Patients With Type 1 DiabetesvTv Therapeutics · Diabetes Mellitus, Type 1CompletedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2020ActualPhase 2NCT03980730Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose TolerancevTv Therapeutics · Alzheimer DiseaseTerminatedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2018ActualPhase 3NCT029160562-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)vTv Therapeutics · Alzheimer's DiseaseTerminatedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2018ActualPhase 3NCT02080364Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's DiseasevTv Therapeutics · Alzheimer's DiseaseTerminatedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2016ActualPhase 2NCT02653599A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 DiabetesvTv Therapeutics · Type 2 Diabetes MellitusCompletedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2016ActualPhase 2NCT02405260Add Glucokinase Activator to Target A1cvTv Therapeutics · Diabetes Mellitus, Type 2CompletedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2013ActualPhase 2NCT01665352A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 DiabetesvTv Therapeutics · Type 2 Diabetes MellitusCompletedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2013ActualPhase 1NCT01548430A Safety Study of TTP4000 in Subjects With Alzheimer's DiseasevTv Therapeutics · Alzheimer's DiseaseCompletedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2012ActualPhase 1/Phase 2NCT01474083A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 DiabetesvTv Therapeutics · Type 2 Diabetes MellitusCompletedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2010ActualPhase 2NCT00909298Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic...vTv Therapeutics · CoagulationTerminatedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2009ActualPhase 2NCT00779519Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight LossvTv Therapeutics · ObesityCompletedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00119457Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)vTv Therapeutics · Venous ThromboembolismCompletedVTVTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00939172TTP607 in Refractory Solid MalignanciesM.D. Anderson Cancer Center · Advanced CancersWithdrawnVTVTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 15 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner